Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Innate antibody catalysis.

G Gololobov1, M Sun, S Paul

  • 1Department of Pathology and Laboratory Medicine, University of Texas Medical School, Houston, TX 77030, USA.

Molecular Immunology
|February 24, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative study on effect of different promoters on expression of cry1Ac in Bacillus thuringiensis chromosome.

Journal of applied microbiology·2007
Same author

A surging new interest on toilet training started during the first months of age in Western countries.

Techniques in coloproctology·2007
Same author

Endoscopic ultrasound-guided interstitial chemotherapy in the pancreas: results in a canine model.

Endoscopy·2007
Same author

Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor.

Canadian journal of physiology and pharmacology·2007
Same author

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study.

Neurology·2006
Same author

c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.

Oncogene·2006

Antibody catalysis, previously thought to require artificial haptens, can arise from innate germline V(L) genes. This study reveals a serine protease-like catalytic triad in an antibody light chain, demonstrating inherent catalytic activity.

Area of Science:

  • Immunology
  • Biochemistry
  • Structural Biology

Background:

  • Antibody catalysis is traditionally linked to immunization with artificial haptens, promoting adaptive immune responses and transition-state binding.
  • The role of germline genes in antibody catalysis has been less explored, with a prevailing assumption of acquired catalytic function.

Purpose of the Study:

  • To investigate the origin of catalytic activity in an antibody light chain raised against vasoactive intestinal peptide (VIP).
  • To determine if the observed catalytic activity is an innate germline function or a result of somatic mutation.

Main Methods:

  • Site-directed mutagenesis was used to identify key catalytic residues (Asp1, Ser27a, His93) in the antibody light chain.
  • The catalytic activity of both the mature and germline V(L) gene configurations was assessed using VIP and a synthetic protease substrate.

Related Experiment Videos

  • Kinetic analysis and inhibition studies with diisopropylfluorophosphate were performed to characterize the catalytic mechanism.
  • Main Results:

    • A serine protease-like catalytic triad (Asp1, Ser27a, His93) was identified in the antibody light chain, functional even in its germline V(L) gene form.
    • The germline light chain exhibited peptidase activity, cleaving VIP and a synthetic substrate, with kinetics comparable to the mature antibody.
    • Inhibition by diisopropylfluorophosphate confirmed the serine protease-like mechanism, and cleavage specificity for basic residues was observed in both forms.

    Conclusions:

    • Antibody catalytic activity can be an innate function encoded within germline V(L) genes, predating somatic diversification.
    • The catalytic triad and its associated peptidase activity are inherited features of the V(L) gene, not solely products of somatic selection.
    • This finding challenges the assumption that antibody catalysis exclusively arises from adaptive immune responses to artificial haptens.